Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848817 · ClinicalTrials.gov registry record
Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software
A clinical trial of Myopia, sponsored by Mann Eye Institute.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05848817: Completed study of Myopia, sponsored by Mann Eye Institute.
NCT05848817 is a study of Myopia that has completed, run by Mann Eye Institute. The registered enrollment target is 50 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05848817, a study of Myopia, has completed, sponsored by Mann Eye Institute.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.
Primary Outcome
Percentage of subjects satisfied with vision after Phorcides Planned Contoura LASIK (answering Completely Satisfied or Very Satisfied on PROWL Questionnaire Question #1.
Conditions Studied
Interventions
- DEVICE Contoura LASIK
Study Locations (1)
Texas
- Mann Eye Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-19 |
| Est. Completion | 2024-08-15 |
What the finished NCT05848817 record still lists
NCT05848817 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Contoura LASIK is the first listed.
NCT05848817 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05848817 about?
NCT05848817 is a clinical study titled "Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software". The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.
What is the current status of trial NCT05848817?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2023-05-19. Estimated completion is 2024-08-15.
What conditions does trial NCT05848817 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT05848817?
The interventions under investigation include: Contoura LASIK (DEVICE).
Who is sponsoring clinical trial NCT05848817?
This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05848817 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05848817's enrollment target sits among peer trials
50 70th of 90 higher than 16 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI